USBC Inc announces stock option repricing and new equity grants for executives and directors

Reuters
Oct 09, 2025
USBC Inc announces stock option repricing and new equity grants for executives and directors

USBC Inc. has announced changes to its executive compensation, including the repricing of stock options granted on August 6, 2025. The exercise price of 48,620,000 outstanding stock options was reduced from $2.45 to $1.10 per share, reflecting the company's closing stock price as of October 7, 2025. Additionally, the board approved the issuance of new ten-year stock options totaling 55,030,000 shares at $1.10 per share, with 25% vesting between the three-month and one-year anniversary of the grant and the remainder vesting quarterly over the next three years. Key recipients include Chief Financial Officer Kitty Payne (1,960,000 options), Chief Operating Officer Kirk Chapman (7,860,000 options), and Director/Vice Chair Linda Jenkinson (5,240,000 options).

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USBC Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001161697-25-000354), on October 08, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10